Category Archives: Events
Latest From Events
Jeff Hatfield, CEO of Vitae Pharmaceuticals, welcomed BIO 2015 to his home town of Philly through a blog post in Life Sci VC, sharing his thoughts on the city’s historic legacy of innovation and collaboration. Hatfield noted: “Innovation is what defines our industry; and collaboration – well, more than 30 thousand collaboration partnering meetings are expected to occur at the convention next week.” The blog post explains that Philadelphia is undergoing an important transition in the Read More >
If you are attending the BIO International Convention and have a particular interest in food and agriculture biotechnology, mark your calendars for Tuesday, June 19 because this day is filled with amazing food and ag events. BIO 2015 offers four Track Sessions which cover key conversations involving the industry such as communication techniques, science and research, legal perspectives, and the international state of the industry. Our honored speakers at these sessions will give viewers a glimpse Read More >
Later this month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science Foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process Read More >
Life Science Leader Asks: What Areas Are Often Overlooked by Academics Turned Biotech Entrepreneurs?
In my third installment of a four-part series interviewing Peter Young, executive-in-residence with A.M. Pappas & Associates, he shared missteps made by academics aspiring to become entrepreneurs and also offered up some advice on partnering with VCs. Check out my interview, which will include lessons that won’t be a part of his 2015 BIO International Convention session, Inventing Your Own Hub: Evolving Institutional Models for Translational Medicine, (June 16, 3:30 p.m.-4:45 p.m., room 105AB) Here is Part 1, Read More >
Emerging therapeutic companies are at their strongest point in a decade. In our new report on investment and deal trends, the BIO Industry Analysis team shows how this segment within the biotech industry has been faring over the last 10 years. The annual aggregate totals show that for almost every funding or deal activity analyzed, 2014 was the peak year of the last decade. A strong public market, a revitalized private funding environment, and a Read More >